Short answer
Janux Therapeutics, Inc. (JANX) filed an 8-K current report with the SEC on June 23, 2026 reporting Item 8.01 (Other Events). Chief Medical Officer William Go, M.D., Ph.D. departed June 23, 2026, in a termination without “Cause”.
Janux Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Chief Medical Officer William Go, M.D., Ph.D. departed June 23, 2026, in a termination without “Cause”
- Successor search underway, with existing clinical leadership assuming interim responsibilities
- Company reaffirmed unchanged development strategy, regulatory plans, and previously disclosed clinical timelines
- Departure reportedly unrelated to disagreements over operations, policies, or practices
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Janux Therapeutics, Inc. 8-K filings
Get the next JANX 8-K as it lands
Follow JANX for push alerts, or ask the research agent what this filing means.